BIOZONE Trademark

Trademark Overview


On Friday, December 4, 2020, a trademark application was filed for BIOZONE with the United States Patent and Trademark Office. The USPTO has given the BIOZONE trademark a serial number of 90359774. The federal status of this trademark filing is REGISTERED as of Tuesday, September 21, 2021. This trademark is owned by Vivera Pharmaceuticals Inc.. The BIOZONE trademark is filed in the Medical Instrument Products category with the following description:

Medical devices for monitoring blood oxygen saturation, blood gas concentrations and vital signs; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, and also featuring a system consisting of communication hardware for transmitting monitored data through the Internet, as a component of the medical devices; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for use in treating or diagnosing infectious disease
biozone

General Information


Serial Number90359774
Word MarkBIOZONE
Filing DateFriday, December 4, 2020
Status700 - REGISTERED
Status DateTuesday, September 21, 2021
Registration Number6490720
Registration DateTuesday, September 21, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 6, 2021

Trademark Statements


Pseudo MarkBIO ZONE
Goods and ServicesMedical devices for monitoring blood oxygen saturation, blood gas concentrations and vital signs; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, and also featuring a system consisting of communication hardware for transmitting monitored data through the Internet, as a component of the medical devices; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for use in treating or diagnosing infectious disease

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, February 10, 2021
Primary Code010
First Use Anywhere DateTuesday, September 1, 2020
First Use In Commerce DateWednesday, September 16, 2020

Trademark Owner History


Party NameVivera Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660

Party NameVivera Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660

Party NameVivera Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660

Trademark Events


Event DateEvent Description
Thursday, March 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 7, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 7, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 7, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 7, 2024WITHDRAWAL OF ATTORNEY GRANTED
Thursday, March 7, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, September 21, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, July 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 6, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 16, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 24, 2021ASSIGNED TO EXAMINER
Wednesday, February 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 8, 2020NEW APPLICATION ENTERED